World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
155
Citations
84800
World Ranking
973
National Ranking
558

Overview

Jorge S. Reis-Filho is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans significant contributions in medicine, particularly within cancer-related fields, combining expertise in biochemistry, genetics, and molecular biology.

Their primary research fields include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study involve cancer-focused areas and diagnostic disciplines such as:

  • Cancer Research
  • Oncology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine

The main topics covered in their work reflect a focus on cancer genomics, diagnostics, and treatment strategies including:

  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Genetic factors in colorectal cancer
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Radiomics and Machine Learning in Medical Imaging

Jorge S. Reis-Filho has contributed extensively to the scientific literature, with frequent publications in notable venues such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Oncology
  • npj Breast Cancer
  • Modern Pathology

Frequent collaborators include:

  • Britta Weigelt
  • Pier Selenica
  • Fresia Pareja
  • Pedram Razavi
  • Sarat Chandarlapaty

Among their recent publications are:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Pathogenesis of Triple-Negative Breast Cancer, 2022, Annual Review of Pathology Mechanisms of Disease
  • ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group, 2022, Annals of Oncology
  • Delivering precision oncology to patients with cancer, 2022, Nature Medicine
  • Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer, 2022, Nature Cancer

Best Publications

  • Triple-negative breast cancer.

    William D. Foulkes;Ian E. Smith;Jorge S. Reis-Filho

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • The landscape of cancer genes and mutational processes in breast cancer

    Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo

  • Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

    Sonja J. Heidorn;Carla Milagre;Steven Whittaker;Arnaud Nourry

  • Basal-Like Breast Cancer: A Critical Review

    Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis

  • Triple negative tumours : a critical review

    J S Reis-Filho;Andrew Tutt;Andrew Tutt

  • RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.

    Fei Su;Amaya Viros;Carla Milagre;Kerstin Trunzer

  • Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer

    Isaac Garcia-Murillas;Gaia Schiavon;Gaia Schiavon;Britta Weigelt;Charlotte Ng

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Resistance to therapy caused by intragenic deletion in BRCA2

    Stacey L. Edwards;Rachel Brough;Christopher J. Lord;Rachael Natrajan

  • Complex landscapes of somatic rearrangement in human breast cancer genomes.

    Philip J. Stephens;David J. Mcbride;Meng-lay Lin;Ignacio Varela

  • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    François-Clément Bidard;François-Clément Bidard;Dieter Peeters;Tanja Fehm;Franco Nolé

  • BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

    Gemma Molyneux;Felipe C. Geyer;Fiona-Ann Magnay;Afshan McCarthy

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • Gene expression profiling in breast cancer: classification, prognostication, and prediction

    Jorge S Reis-Filho;Lajos Pusztai

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

    Pedram Razavi;Matthew T. Chang;Guotai Xu;Chaitanya Bandlamudi

  • FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

    Nicholas Turner;Alex Pearson;Rachel Sharpe;Maryou Lambros

Frequent Co-Authors

Charlotte K.Y. Ng
Charlotte K.Y. Ng Humanitas University
Rachael Natrajan
Rachael Natrajan Institute of Cancer Research
Alan Ashworth
Alan Ashworth University of California, San Francisco
Salvatore Piscuoglio
Salvatore Piscuoglio Humanitas University
Alan Mackay
Alan Mackay Institute of Cancer Research
Sunil R. Lakhani
Sunil R. Lakhani University of Queensland
Ian O. Ellis
Ian O. Ellis University of Nottingham
Edi Brogi
Edi Brogi Memorial Sloan Kettering Cancer Center
Christopher J. Lord
Christopher J. Lord Institute of Cancer Research
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a future in medicine but interested in flexible learning, online healthcare programs provide an accessible route into the field. Options range from entry-level to advanced degrees and touch on numerous career opportunities within healthcare.

A popular starting point is earning the cheapest online healthcare administration degree. This degree is ideal for students who wish to move into healthcare management or administrative roles without the commitment of medical school. For those seeking leadership or specialized positions, a master's in healthcare administration online builds on foundational knowledge and opens doors to advanced supervisory roles.

Alternatively, nurses who wish to expand their impact might explore the cheapest online bsn to dnp programs, leading to a Doctor of Nursing Practice. For those interested in pharmaceuticals, online pharmacy school programs allow aspiring pharmacists to pursue their doctorate with flexibility.

Exploring these related online degrees can be a practical and affordable way to launch or advance a healthcare career, whether you are entering the field or seeking to specialize further.

Best Scientists Citing Jorge S. Reis-Filho

Trending Scientists

Recently Published Articles